Trump’s bud­get takes a big bite out of the NIH, with big new fees for bio­phar­ma

Pres­i­dent Don­ald Trump’s new bud­get is hit­ting the ta­ble to­day and bio­med­ical re­search is out, FDA fees are up and mil­i­tary spend­ing is in.

The Wash­ing­ton Post got the de­bate start­ed ear­ly Thurs­day, re­veal­ing that the new bud­get in­cludes an enor­mous $5.8 bil­lion cut in the NIH’s bud­get, close to 20%.

To get that, Trump’s team en­vi­sions a ma­jor re­or­ga­ni­za­tion of the NIH, which funds thou­sands of re­search projects and pro­vides much of the foun­da­tion work for pre­clin­i­cal drug re­search. The NIH has al­so been mov­ing more in­to trans­la­tion­al ef­forts aimed at vault­ing these pro­grams ahead, with an eye to see­ing more drugs point­ed to the mar­ket.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER